I]FP-CIT SPECT(DaTSCAN)may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms:a meta-analysis. Eur J Neurol 21:1369-e90, 2014
2) Chrounard G:Severe cases of neroleptic-induced supersensitivty psychosis. Diagnostic criteria for the disorder and its treatment. Schozophr Res 5:21-33, 1991
3) Foubert-Samier A, Helmer C, Perez F, et al:Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort. Neurology 79:1615-1621, 2012
4) 林眞弘,東光太郎,堺奈々:統合失調症にパーキンソン病を併発し抗パーキンソン病治療にて運動症状・精神症状とも著明な改善を呈したケース.精神科治療学 31:1089-1094, 2016
I-ioflupane SPECT(DaTSCAN)の検討.最新精神医学 22:59-63, 2017
6) Mori H, Kondo T, Yokochi M, et al:Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neulology 51:890-892, 1998
静注 添付文書(第2版),2014
8) 日本神経学会監修,「パーキンソン病治療ガイドライン」作成委員会編:パーキンソン病治療ガイドライン2011.医学書院,2011
9) Nuvoli S, Spanu A, Piras MR, et al:123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders. Medicine(Baltimore)96:e6967. doi:10.1097MD0000000000006967, 2017
10) Stanley K, Lewis O, Abraham F(山田寛,増井寛治,菊本弘次訳):陽性症状・陰性症状評価尺度(PANSS)マニュアル.星和書店,pp11-17, 1991
11) Tinazzi M, Morgante F, Matinella A, et al:Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism:a 2-year follow-up multicenter study. Schizophr Res 152:344-349, 2014
12) Treglia G, Cason E, Stefanelli A, et al:MIBG scintigraphy in differential diagnosis of Parkinsonism:a meta-analysis. Clin Auton Res 22:43-55, 2012
I-MIBG心筋シンチグラフィにおける薬物の影響.精神医学 49:437, 2007